Table 2:
Models using General Obesity | Models using Overweight Status | Models using BMI | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
(BMI ≥30 vs. <30) | (BMI ≥25 vs. <25) | (continuous measures) | |||||||||||||
Dependent Variable |
Variable | Odds Ratio (OR) |
Lower 95% CI |
Upper 95% CI |
FDR adjusted p-value |
Variable | Odds Ratio (OR) |
Lower 95% CI |
Upper 95% CI |
FDR adjusted p-value |
Variable | Odds Ratio (OR) |
Lower 95% CI |
Upper 95% CI |
FDR adjusted p-value |
UI (odds of having any UI) |
General Obesity |
1.443 | 1.058 | 1.968 | 0.028 | Overweight | 1.323 | 0.922 | 1.898 | 0.160 | BMI (per 5 units) |
1.202 | 1.063 | 1.359 | 0.006 |
Female vs. Male |
4.644 | 3.386 | 6.369 | <0.001 | Female vs. Male |
4.832 | 3.518 | 6.636 | <0.001 | Female vs. Male |
4.641 | 3.382 | 6.369 | <0.001 | |
SUI (in Females only) # |
General Obesity |
1.931 | 1.132 | 3.296 | 0.023 | Overweight | 1.395 | 0.792 | 2.457 | 0.283 | BMI (per 5 units) |
1.318 | 1.087 | 1.599 | 0.009 |
UUI | General Obesity | 1.857 | 1.316 | 2.619 | 0.001 | Overweight | 1.280 | 0.840 | 1.949 | 0.283 | BMI (per 5 units) |
1.305 | 1.142 | 1.492 | <0.001 |
Female vs. Male |
6.387 | 4.526 | 9.012 | <0.001 | Female vs. Male |
7.081 | 4.973 | 10.084 | <0.001 | Female vs. Male |
6.377 | 4.514 | 9.009 | <0.001 | |
Hypertension (Yes vs. No) |
1.487 | 1.015 | 2.178 | 0.059 | |||||||||||
OAB | General Obesity – Males |
1.157 | 0.787 | 1.699 | 0.502 | Overweight | 1.778 | 1.285 | 2.461 | 0.001 | BMI (per 5 units) Male |
1.047 | 0.886 | 1.238 | 0.588 |
General Obesity – Females |
2.432 | 1.576 | 3.753 | <0.001 | BMI (per 5 units) Female |
1.385 | 1.182 | 1.623 | <0.001 | ||||||
Female vs. Male |
2.220 | 1.665 | 2.960 | <0.001 | |||||||||||
Age (per 10 years) |
1.141 | 1.030 | 1.263 | 0.019 | Age (per 10 years) |
1.129 | 1.019 | 1.251 | 0.037 | Age (per 10 years) |
1.135 | 1.025 | 1.257 | 0.021 | |
OAB with UUI vs. without UUI (among those with OAB only) ^ |
General Obesity |
1.789 | 1.22 | 2.624 | 0.007 | Overweight | 1.132 | 0.708 | 1.811 | 0.628 | BMI (per 5 units) |
1.26 | 1.079 | 1.472 | 0.006 |
Female vs. Male |
4.498 | 3.073 | 6.585 | <0.001 | Female vs. Male |
4.716 | 3.230 | 6.885 | <0.001 | Female vs. Male |
4.449 | 3.039 | 6.512 | <0.001 | |
Urgency Symptoms |
General Obesity – Males |
1.217 | 0.828 | 1.789 | 0.366 | Overweight | 1.671 | 1.190 | 2.346 | 0.008 | BMI (per 5 units) |
1.22 | 1.083 | 1.375 | 0.003 |
General Obesity – Females |
2.573 | 1.566 | 4.228 | 0.001 | |||||||||||
Female vs. Male |
3.009 | 2.226 | 4.066 | <0.001 | Female vs. Male |
2.812 | 2.086 | 3.792 | <0.001 | ||||||
Black vs. Non-Black |
1.742 | 1.022 | 2.969 | 0.050 | Black vs. Non-Black |
1.790 | 1.052 | 3.046 | 0.052 | ||||||
Frequency Symptoms |
General Obesity |
1.597 | 1.149 | 2.22 | 0.010 | Overweight | 1.229 | 0.848 | 1.782 | 0.300 | BMI (per 5 units) |
1.227 | 1.077 | 1.397 | 0.005 |
Black vs. Non-Black |
2.248 | 1.172 | 4.313 | 0.023 | Black vs. Non-Black |
2.266 | 1.181 | 4.350 | 0.028 | Black vs. non- Black |
2.19 | 1.14 | 4.207 | 0.026 | |
Hypertension (Yes vs. No) |
1.405 | 1.004 | 1.968 | 0.062 | |||||||||||
Nocturia ≥1 | General Obesity |
1.132 | 0.737 | 1.74 | 0.598 | Overweight | 1.600 | 1.015 | 2.523 | 0.059 | BMI (per 5 units) Males |
0.792 | 0.598 | 1.049 | 0.116 |
BMI (per 5 units) Female |
1.185 | 0.986 | 1.425 | 0.082 | |||||||||||
Female vs. Male |
0.525 | 0.335 | 0.823 | 0.010 | Female vs. Male |
0.544 | 0.347 | 0.853 | 0.019 | ||||||
Age (per 10 years) |
1.311 | 1.131 | 1.521 | 0.001 | Age (per 10 years) |
1.305 | 1.124 | 1.515 | 0.001 | Age (per 10 years) |
1.316 | 1.132 | 1.529 | 0.001 | |
Dyslipidemia (Yes vs. No) |
1.894 | 1.057 | 3.394 | 0.041 | Dyslipidemia (Yes vs. No) |
1.832 | 1.020 | 3.289 | 0.059 | Dyslipidemia (Yes vs. No |
1.854 | 1.031 | 3.335 | 0.047 | |
Nocturia ≥2 | General Obesity |
1.028 | 0.779 | 1.357 | 0.845 | Overweight | 0.993 | 0.716 | 1.377 | 0.966 | BMI (per 5 units) |
1.029 | 0.93 | 1.139 | 0.588 |
Female vs. Male |
0.728 | 0.551 | 0.961 | 0.044 | Female vs. Male |
0.723 | 0.547 | 0.955 | 0.03 | ||||||
Age (per 10 years) |
1.374 | 1.236 | 1.528 | <0.001 | Age (per 10 years) |
1.355 | 1.218 | 1.507 | <0.001 | Age (per 10 years) |
1.355 | 1.218 | 1.507 | <0.001 | |
Black vs. Non-Black |
2.833 | 1.728 | 4.643 | <0.001 | Black vs. Non-Black |
2.862 | 1.741 | 4.703 | <0.001 | Black vs. non- Black |
2.815 | 1.713 | 4.626 | <0.001 | |
Dyslipidemia (Yes vs. No) |
1.547 | 1.135 | 2.109 | 0.010 | Dyslipidemia (Yes vs. No) |
1.493 | 1.092 | 2.039 | 0.026 | Dyslipidemia (Yes vs. No) |
1.478 | 1.081 | 2.021 | 0.021 |
Males with a history of prostate cancer were excluded from the study. Since male SUI was rare, only female SUI was analyzed.
Comparing OAB with UUI versus OAB without UUI (“OAB-wet” versus “OAB-dry”).
Abbreviations: CI = confidence limit; FDR = false discovery rate; OAB = overactive bladder syndrome; SUI = stress urinary incontinence; UI = urinary incontinence; UUI = urgency urinary incontinence